We found KCTD9 was commonly downregulated at the mRNA and protein level in CRC tissues and stratification according to KCTD9 expression showed that downregulation of KCTD9 was correlated with poorer patient outcomes. This evidence concerns the gene KCTD9 and colorectal carcinoma.